MPI Research Competitors and Similar CompaniesClear all
Bio-Path Holdings's competitors and similar companies include Kyowa Kirin.
 Bio-Path Holdings Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company. |  Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. | |
Founding Date | Founding Date 2007 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Bellaire, US HQ | |
Employees | Employees 913% increase | Employees 5,669 |
Valuation ($) | Valuation ($) 4 m | Valuation ($) 8.8 b |
Financial | ||
Net income | Net income ($9.9m) (FY, 2024) | Net income ¥67b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Kyowa Kirin
HQ
Tokyo, JP
Employees
5,669
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
View company